Navigation Links
HIV Treatment Said to Increase Heart Attack Risk

A common treatment option for HIV patients is associated with an increased risk for a heart attack, according to a new study. However, researchers say the benefit of the treatment outweighs the risk of a //heart attack for most patients.

Combination antiretroviral therapy substantially improves the prognosis of HIV-infected patients at risk for AIDS. Before this therapy was available, the annual mortality rate among patients with HIV infection exceeded 20 percent.

In the current research, the mortality rate was 2 percent. While the benefits of combination antiretroviral therapy are clear, there is a concern about the treatment being associated with adverse side effects. These side effects include high cholesterol and triglycerides, insulin resistance and diabetes. These problems can lead to cardiovascular problems.

Researchers in Denmark conducted a study to determine if exposure to combination antiretroviral treatment increases the risk of a heart attack. They looked at information on more than 23,000 patients from 11 previous studies. They collected follow-up information on the patients about their HIV and if they had suffered a heart attack.

Researchers collected data over a period of 36,199 person-years. They found 126 patients had a heart attack. They say the incidence of a heart attack increased with longer exposure to combination antiretroviral therapy. They also say factors such as older age, current or former smoking, previous cardiovascular disease and male sex also increased the risk for a heart attack. Furthermore, a higher cholesterol level, a higher triglyceride level and diabetes were associated with an increased risk for a heart attack.

Investigators conclude combination antiretroviral therapy was independently associated with a 26-percent increase in the rate of a heart attack. However, they point out the risk has to be balanced against the benefits from the antiretroviral treatment. They add tha t heart disease can take decades to develop, so further follow-up research is needed to determine the absolute risk of cardiovascular disease.


'"/>




Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected ... Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the position ... the end of 2018. Upon assuming the role of President and CEO on January ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a ... utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the ... a CBD form that can be easily incorporated into liquid products, while reducing costs ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Lori R. Somekh, ... member of ElderCounsel, a national organization of elder law and special needs planning attorneys. ... and rules. It also provides a forum to network with elder law attorneys nationwide,” ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017 Halo Labs announces the European launch ... called the HORIZON at MIBio 2017 in Cambridge, U.K ... visible particulate matter in biopharmaceutical samples with unprecedented speed and sensitivity ... novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/27/2017)...  Commended for their devotion to personalized service, SMP Pharmacy ... one in the South Florida Business Journal,s 50 Fastest-Growing Companies, ... list, the national specialty pharmacy has found its niche.  To ... soon be honored by SFBJ as the 2017 Power Leader ... to receive his award in October, Bardisa said of the ...
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
Breaking Medicine Technology: